Ознакомительная версия. Доступно 16 страниц из 80
3. W. O. Thompson, “Uses and Abuses of the Male Sex Hormone,” Journal of the American Medical Association 132, no. 4 (1946): 185–187; Blakeslee, “Stimulant Found in Pituitary Powder.”
4. Beach, “Locks and Beagles.”
5. Andrea Busnelli et al., “‘Forever Young’—Testosterone Replacement Therapy: A Blockbuster Drug Despite Flabby Evidence and Broken Promises,” Human Reproduction 32, no. 4 (2017): 719–724.
6. Alvaro Morales, “The Long and Tortuous History of the Discovery of Testosterone and Its Clinical Application,” Journal of Sexual Medicine 10, no. 4 (2013): 1178–1183.
7. T. F. Gallagher and Fred C. Koch, “The Testicular Hormone,” Journal of Biological Chemistry 84, no. 2 (1929): 495–500.
8. Claudia Dreifus, “A Conversation with – Anne Fausto-Sterling; Exploring What Makes Us Male or Female,” New York Times, January 2, 2001; Anne Fausto-Sterling, Sexing the Body (New York: Basic Books, 2000).
9. “Science Finds Way to Produce Male Hormone Synthetically,” New York Herald Tribune, September 16, 1935; “Chemist Produces Potent Hormone,” New York Times, September 16, 1935; “Testosterone,” Time, September 23, 1935.
10. “Testosterone,” Time.
11. Sarita Metzger and Arthur L. Burnett, “Impact of Recent FDA Ruling on Testosterone Replacement Therapy (TRT),” Translational Andrology and Urology 5, no. 6 (2016): 921–926. Пример выпуска новостей: Julie Revelant, “10 Warning Signs of Low Testosterone Men Should Never Ignore,” Fox News Health, July 18, 2016, http://www.foxnews.com/health/2016/07/18/10-warning-signs-low-testosterone-men-should-never-ignore.html.
12. August Werner, “The Male Climacteric,” Journal of the American Medical Association 112, no. 15 (1939): 1441.
13. Доктор Джон Морли, интервью автора.
14. Stephen R. Braun, “Promoting ‘Low T’: A Medical Writer’s Perspective,” JAMA Internal Medicine 173, no. 15 (2013): 1458–1460.
15. Стивен Браун, интервью автора.
16. C. Lee Ventola, “Direct-to-Consumer Pharmaceutical Advertising: Therapeutic or Toxic?” Pharmacy and Therapeutics 36, no. 10 (2011): 669–684; Samantha Huo et al., “Treatment of Men for ‘Low Testosterone’: A Systematic Review,” PLOS ONE 11, no. 9 (2016): e0162480.
17. Hoberman, Testosterone Dreams, 120.
18. Metzger and Burnett, “Impact of Recent FDA Ruling.”
19. Shalender Bhasin et al., “Testosterone Therapy in Adult Men with Androgen Defi ciency Syndromes: An Endocrine Society Clinical Practice Guidline,” Journal of Clinical Endocrinology and Metabolism 95, no. 6 (2010): 2536–2559; Frederick Wu et al., “Identifi cation of Late-Onset Hypogonadism in Middle-Aged and Elderly Men,” New England Journal of Medicine 363, no. 2 (2010): 123–135; G. R. Dohle et al., “Guidelines on Male Hypogonadism,” European Association of Urology, 2014, http://uroweb.org/wp-content/uploads/18-Male-Hypogonadism_LR1.pdf.
20. Joseph Scott Gabrielsen et al., “Trends in Testosterone Prescription and Public Health Concerns,” Urologic Clinics of North America 43, no. 2 (2016): 261–271; Katherine Margo and Robert Winn, “Testosterone Treatments: Why, When, and How?” American Family Physician 73, no. 9 (2006): 1591–1598.
21. L. M. Schwartz and S. Woloshin, “Low ‘T’ as in ‘Template’: How to Sell Disease,” JAMA Internal Medicine 173, no. 15 (2013): 1460–1462.
22. W. J. Bremner et al., “Loss of Circadian Rhythmicity in Blood Testosterone Levels with Aging in Normal Men,” Journal of Clinical Endocrinology and Metabolism 56, no. 6 (1983): 1278–1281.
23. Fred Sattler et al., “Testosterone and Growth Hormone Improve Body Composition and Muscle Performance in Older Men,” Journal of Clinical Endocrinology and Metabolism 94, no. 6 (2009): 1991–2001.
24. Доктор Александр Пастушак, интервью автора.
25. A. M. Matsumoto, “Effects of Chronic Testosterone Administration in Normal Men: Safety and Effi cacy of High Dosage Testosterone and Parallel Dose-Dependent Suppression of Luteinizing Hormone, Follicle-Stimulating Hormone, and Sperm Production,” Journal of Clinical Endocrinology and Metabolism 70, no. 1 (1990): 282–287.
26. L. Frederiksen et al., “Testosterone Therapy Decreases Subcutaneous Fat and Adiponectin in Aging Men,” European Journal of Endocrinology 166 (2012): 469–476.
27. Shehzad Basaria et al., “Adverse Events Associated with Testosterone Administration,” New England Journal of Medicine 363, no. 2 (2010): 109–122; S. Basaria et al., “Effects of Testosterone Administration for 3 Years on Subclinical Atherosclerosis Progression in Older Men with Low or Low-Normal Testosterone Levels: A Randomized Clinical Trial,” Journal of the American Medical Association 314, no. 6 (2015): 570–581.
28. P. J. Snyder et al., “Effects of Testosterone Treatment in Older Men,” New England Journal of Medicine 374, no. 7 (2016): 611–624.
29. Felicitas Buena et al., “Sexual Function Does Not Change when Serum Testosterone Levels Are Pharmacologically Varied within the Normal Male Range,” Fertility and Sterility 59, no. 5 (1993): 1118–1123; Christina Wang et al., “Transdermal Testosterone Gel Improves Sexual Function, Mood, Muscle Strength, and Body Composition Parameters in Hypogonadal Men,” Journal of Clinical Endocrinology and Metabolism 85, no. 8 (2000): 2839–2853.
30. Доктор Шалендер Бхасин, интервью автора.
31. Darius Paduch et al., “Testosterone Replacement in Androgen-Defi cient Men With Ejaculatory Dysfunction: A Randomized Controlled Trial,” Journal of Clinical Endocrinology and Metabolism 100, no. 8 (2015): 2956–2962; Snyder et al., “Effects of Testosterone Treatment in Older Men.”
32. S. M. Resnick et al., “Testosterone Treatment and Cognitive Function in Older Men With Low Testosterone and Age-Associated Memory Impairment,” Journal of the American Medical Association 317, no. 7 (2017): 717–727.
33. Partnership for the Accurate Testing of Hormones, “PATH Fact Sheet: The Importance of Accurate Hormone Tests,” Endocrine Society, Washington DC, 2017.
34. Доктор Мохит Кера, интервью автора. Mohit Khera et al., “Adult-Onset Hypogonadism,” Mayo Clinic Proceedings 91, no. 7 (2016): 908–926. Mohit Khera, “Male Hormones and Men’s Quality of Life,” Current Opinion in Urology 26, no. 2 (2016): 152–157.
35. Joel S. Finkelstein et al., “Gonadal Steroids and Body Composition, Strength, and Sexual Function in Men,” New England Journal of Medicine 369, no. 11 (2013): 1011–1022.
36. Eder, “The Birth of Gender,” 83.
37. Natasha Singer, “Selling That New-Man Feeling,” New York Times, November 23, 2013; Sky Chadde, “How the Low T Industry Is Cashing in on Dubious, and Perhaps Dangerous, Science,” Dallas Observer, November 12, 2014; Sarah Varney, “Testosterone, The Biggest Men’s Health Craze Since Viagra, May Be Risky,” Shots: Health News from NPR, April 28, 2014, www.npr.org/sections/healthshots/2014/04/28/305658501/
Ознакомительная версия. Доступно 16 страниц из 80
